SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Damaged Protein Reveals Parkinson’s Destructive Course, University of Pennsylvania Study
November 16, 2012
 · 
1 min read
Drug Development
Poor Sleep Can Lead to Schizophrenia Symptoms, University of Bristol Study
November 15, 2012
 · 
1 min read
Drug Development
How Chronic Inflammation Can Cause Cancer, Ohio State University Study
November 13, 2012
 · 
1 min read
Drug Development
“Calm Down” Genes Treat Epilepsy in Rats, University College London Study
November 13, 2012
 · 
1 min read
Drug Development
It’s Not Just What You Eat, But When You Eat It, University of Pennsylvania Study
November 12, 2012
 · 
1 min read
Drug Development
Social Isolation Disrupts Brain’s “White Matter” Formation, University at Buffalo and Mount Sinai School of Medicine Study
November 12, 2012
 · 
1 min read
Drug Development
Magnet Helps Target Transplanted Iron-Loaded Cells to Key Areas of Heart, INSERM Study
June 29, 2012
 · 
1 min read
Drug Development
Why Eating Fish Boosts Brainpower, University of Alberta Study
June 29, 2012
 · 
1 min read
Drug Development
Combination Therapy Shows Potent Tumor Growth Inhibition in Preclinical Studies, Regeneron Pharmaceuticals, Inc. Reveals
December 2, 2011
 · 
1 min read
Drug Development
Rats on Antidepressants Showed Signs of Autism, University of Mississippi Medical Center Study
October 27, 2011
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 2026
February 19, 2026
 · 
2 min read
Press Releases
Ankyra Therapeutics Presents First Preclinical Data on ANK-203, a Novel CD137-Anchored Immunotherapy Candidate, in Oral Session at AACR IO
February 18, 2026
 · 
3 min read
Press Releases
Vyome Announces the Publication of Positive Preclinical Results in Uveitis, Addressing a $3B Potential Market Opportunity
February 18, 2026
 · 
6 min read
Press Releases
BIOEMTECH and NorthStar Medical Radioisotopes Announce Strategic Supply Agreement for Actinium-225 to Support Preclinical Radiopharmaceutical Research
February 17, 2026
 · 
3 min read
Press Releases
Nimbus Therapeutics to Present Preclinical and Translational Data on Novel SIK2 Inhibitors at 21st Congress of European Crohn’s and Colitis Organisation (ECCO)
February 17, 2026
 · 
3 min read
Press Releases
Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases
February 17, 2026
 · 
7 min read
Press Releases
Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntington’s Disease and Establishes Clinical Advisory Board
February 16, 2026
 · 
9 min read
Press Releases
J INTS BIO Reports Fourth-Generation EGFR Inhibitor JIN-A02 in Clinical Cancer Research
February 12, 2026
 · 
4 min read
Press Releases
Madrigal Expands its MASH Pipeline with Exclusive Global Licensing Agreement for Six Preclinical siRNA Programs
February 11, 2026
 · 
10 min read
Press Releases
Zelluna selects Medpace as CRO for ZIMA-101 first-in-human clinical trial
February 11, 2026
 · 
3 min read
Press Releases
Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™
February 10, 2026
 · 
8 min read
Press Releases
Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Type 2 Immune Diseases, at the 2026 AAAAI Annual Meeting
February 10, 2026
 · 
2 min read
Press Releases
IRBM Reports Breakthrough in Zika Virus Drug Discovery
February 10, 2026
 · 
3 min read
Press Releases
Insilico Medicine Nominates ISM5059, the Peripheral-restricted NLRP3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications
February 5, 2026
 · 
4 min read
Press Releases
Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment
February 3, 2026
 · 
6 min read
Press Releases
Kazia Therapeutics Announces Compelling Preclinical and Translational Data for Nuclear PD-L1 Degrader (NDL2)
February 1, 2026
 · 
11 min read
Press Releases
LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
January 30, 2026
 · 
5 min read
Press Releases
Asthma and Allergy Drug Development Is Failing Too Often--A Translational Reset Is Needed: HKEY-AIRx™1.0
January 28, 2026
 · 
4 min read
Press Releases
Aclaris Therapeutics’ Novel ITK/JAK3 Inhibitor ATI-2138 Demonstrates Rapid and Sustained Hair Regrowth in Validated Murine Model of Alopecia Areata (AA)
January 27, 2026
 · 
6 min read
Press Releases
Nocion Therapeutics to Present Preclinical Data Supporting Nocions™ as a Novel Approach for the Treatment of Pain at the Non-Opioid Pain Therapeutics Summit
January 27, 2026
 · 
3 min read
Load More